申请人:Boehringer Ingelheim International GmbH
公开号:US20160340339A1
公开(公告)日:2016-11-24
The present invention encompasses compounds of the formula (I) wherein the groups R
1
, Cy, and Y are defined herein, which are suitable for the treatment of diseases related to BTK, process of making, pharmaceutical preparations which contain compounds and their methods of use.